In this enlightening blog post, Dr. Andrew Alexis, an esteemed Professor of Clinical Dermatology, delves into the intricacies of diagnosing and treating psoriasis in skin of color patients. He highlights the challenges these patients face, the impact on their quality of life, and provides essential treatment recommendations for pigmentary sequelae. Moreover, Dr. Alexis sheds light on the pressing need for inclusive clinical trials to improve psoriasis care in diverse populations. This comprehensive article offers invaluable insights for healthcare providers and patients alike.
Commentary: Psoriasis comprehensive review
Lars Iversen, MD, DMSc
Aarhus University Hospital
Aarhus, Denmark
IPC Board Member
PUBLICATION
Psoriasis. Griffiths C, Armstrong A, Gudjonsson J, Barker J. Lancet. vol. 397. no. 10281. 2021 Apr; 397: 1301–15. doi: 10.1016/s0140-6736(20)32549-6.
COMMENTARY
In the April 2021 issue of the Lancet, four of our esteemed colleagues in the IPC published an updated and comprehensive review of the current pieces of knowledge on psoriasis.
It is a very well-written review covering all aspects of psoriasis spanning from epidemiology and pathophysiology to clinical presentation, associated diseases, and the management of psoriasis. Alongside an update of the most recently published literature in the field of psoriasis, the manuscript is also accompanied by clear clinical pictures, figures that elegantly explain the pathogenesis of psoriasis, and tables that provide a good overview of the different treatment options.
The review is up-to-date and discusses the current knowledge and challenges in managing psoriasis during the SARS-CoV-2 pandemic and nicely points out future directions of psoriasis research by highlighting unresolved questions, new developments, and unmet medical needs. Because of the comprehensive nature of this manuscript, it appeals to those who want to gain an overview of the various aspects of psoriasis and those who are searching for an in-depth understanding of specific aspects of psoriasis and its subtypes such as their different pathophysiologies.
This manuscript will undoubtedly serve as a critical reference paper in the field of psoriasis in the coming years.
Categories
Recent Posts
Shining a Spotlight on our 2022 Fellows: Get to Know the Future Leaders in Psoriasis – Albert Duvetorp, MD, PhD
Medical Adherence in Topical Agents in the Context of Psoriasis Patients
Commentary: The Next Era of Opportunity in Psoriasis: Spatial Transcriptomics
Also Read
Medical Adherence in Topical Agents in the Context of Psoriasis Patients
Explore the challenges, solutions, and breakthroughs in improving psoriasis treatment adherence. Discover the latest strategies and steroid-free topical agents transforming dermatological care.
Commentary: The Next Era of Opportunity in Psoriasis: Spatial Transcriptomics
Nicole Ward explores groundbreaking psoriatic disease research methods published in recent literature. Discover how Spatial Transcriptomics and Single Cell Sequencing unveil new cellular players and pathways, opening doors to novel drug targets and advancing psoriasis research and medicine.
Recognizing Clinical Gaps in Skin of Color Patients
In this enlightening blog post, Dr. Andrew Alexis, an esteemed Professor of Clinical Dermatology, delves into the intricacies of diagnosing and treating psoriasis in skin of color patients. He highlights the challenges these patients face, the impact on their quality of life, and provides essential treatment recommendations for pigmentary sequelae. Moreover, Dr. Alexis sheds light on the pressing need for inclusive clinical trials to improve psoriasis care in diverse populations. This comprehensive article offers invaluable insights for healthcare providers and patients alike.
Subscribe to the IPC Newsletter